Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
UK Biobank to Study Protein Changes Across 600,000 Samples

UK Biobank to Study Protein Changes Across 600,000 Samples

New Platform Simplifies Protein-Protein Interaction Measurements

New Platform Simplifies Protein-Protein Interaction Measurements

New Study Reveals DNA’s Role in Stabilizing Cellular Structures

New Study Reveals DNA’s Role in Stabilizing Cellular Structures

A Novel Method for Synthesizing Piperidines for Modern Medicine

A Novel Method for Synthesizing Piperidines for Modern Medicine

New Imaging Method Reveals Sharper Layers of Cells in Living Tissue

New Imaging Method Reveals Sharper Layers of Cells in Living Tissue

Key Enzymes Identified as Regulators of Cancer Cell Nutrient Foraging

Key Enzymes Identified as Regulators of Cancer Cell Nutrient Foraging

The Immune System’s Role in Neurodegenerative Disease

The Immune System’s Role in Neurodegenerative Disease

Human Cell Atlas Consortium Makes Major Progress in Understanding the Human Body

Human Cell Atlas Consortium Makes Major Progress in Understanding the Human Body

New Bioluminescent Proteins Enable Excitation-Free Imaging in Living Organisms

New Bioluminescent Proteins Enable Excitation-Free Imaging in Living Organisms

Domainex Integrates Nuclera’s eProtein Discovery System to Enhance Drug Discovery Services

Domainex Integrates Nuclera’s eProtein Discovery System to Enhance Drug Discovery Services

Predicting Disease-Causing Protein Interactions with PIONEER

Predicting Disease-Causing Protein Interactions with PIONEER

Personalized Mini-Brains Provide Insight into Autism Spectrum Disorder

Personalized Mini-Brains Provide Insight into Autism Spectrum Disorder

Melanin May Act as a "Drug Sponge," Influencing Medication Effectiveness

Melanin May Act as a "Drug Sponge," Influencing Medication Effectiveness

Researchers Develop Highly Selective SARS-CoV-2 Mpro Inhibitors

Researchers Develop Highly Selective SARS-CoV-2 Mpro Inhibitors

Fighting Drug-Resistant TB with a Novel Antibiotic

Fighting Drug-Resistant TB with a Novel Antibiotic

Discovering New Drug Targets Through Paralog Hopping

Discovering New Drug Targets Through Paralog Hopping

New AI Model ProteinGenerator Revolutionizes Protein Design with Sequence and Structure Integration

New AI Model ProteinGenerator Revolutionizes Protein Design with Sequence and Structure Integration

One-Third of Antibody Drugs Show Unintended Target Binding

One-Third of Antibody Drugs Show Unintended Target Binding

A Novel Method for Incorporating Non-Canonical Amino Acids into Proteins

A Novel Method for Incorporating Non-Canonical Amino Acids into Proteins

Crystal Structure of i-Motif DNA Opens Doors for Targeted Drug Design

Crystal Structure of i-Motif DNA Opens Doors for Targeted Drug Design

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.